Halting the Epidemic of Addiction and Loss Act of 2025
Official title: A bill to ensure references to opioid overdose reversal agents in certain grant programs of the Department of Health and Human Services are not limited to naloxone.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Halting the Epidemic of Addiction and Loss Act of 2025
This bill requires that, when the Department of Health and Human Services (HHS) issues new regulations or guidance on grant programs addressing opioid use disorders, references to an opioid overdose reversal drug (e.g., naloxone) must broadly include any opioid overdose reversal drug approved by the Food and Drug Administration.
Within one year after the bill’s enactment, HHS must update all references accordingly in regulations or guidance issued prior to the bill’s enactment that are applicable to State Opioid Response Grants, Tribal Opioid Response Grants, or certain other grants relating to substance use disorder prevention.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2336: Halting the Epidemic of Addiction and Loss Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-S-2336/
"S. 2336: Halting the Epidemic of Addiction and Loss Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-2336/.
S. 2336, 119th Cong. (2026), https://openamerica.io/bill/119-S-2336/.
[S. 2336: Halting the Epidemic of Addiction and Loss Act of 2025](https://openamerica.io/bill/119-S-2336/)